NOVA – No significant difference in rate of post-op AF with botulinum toxin vs placebo
Key Points: -In a Phase II, dose-ranging trial of epicardial fat pad…
Amulet IDE: Continued safety and effectiveness of the Amulet LAA occluder device at three years in patients with nonvalvular atrial fibrillation
Key Points: In 2021, the Amulet IDE study demonstrated that the novel…
ILR use led to increased diagnosis of Atrial Fibrillation, but no reduction in stroke or arterial embolism noted: Results from LOOP
Key Points: • In the LOOP trial, patients at high risk of…
Acute alcohol consumption elevates risk of AF event
Presented as a Late Breaking Clinical Trial at the American College of…
STOP AF First Trial: Cryoballoon Ablation Is Superior to Antiarrhythmic Drug Therapy for the Prevention of Atrial Arrhythmia Recurrence in Patients With Paroxysmal Atrial Fibrillation
A recent trial by Dr. Oussama M. Wazni, published in the New…
ADRIFT Study: Reduced Rivaroxaban Doses Are Associated With Lower Thrombin Generation Following Percutaneous Left Atrial Appendage Closure Compared to Dual Antiplatelet Therapy
A recent study by Dr. Duthoit, MD, published in Circulation: Cardiovascular Interventions,…
Integrated Management of Atrial Fibrillation in Primary Care Demonstrates 45% Reduction in All-Cause Mortality Compared to Usual Care in Elderly Patients
In a recent Dutch study, published in European Heart Journal, integrated care for…
Trial Shows Abstinence From Alcohol Can Reduce Recurrence of Atrial Fibrillation In Patients With Paroxysmal Atrial Fibrillation Who Regularly Consume Alcohol
In an original study conducted by Dr. Aleksandr Voskoboinik et al. recently…
The Sarcomeric Human Cardiomyopathy Registry: Race Associated with Disease Expression and Clinical Outcomes Among Patients with Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy (HCM) is the most common inherited genetic disorder of the…
New-Onset AF After TAVR linked To Worse Long-Term Outcomes Compared With Patients With Pre-Existing AF and No AF
A registry-based cohort study including 72,660 Medicare patients with and without atrial…
ADRIFT Trial: Low-Dose Rivaroxaban is Superior to Dual Antiplatelet Therapy for Controlling Thrombin Generation after Left Atrial Appendage Closure in Atrial Fibrillation Patients
According to the results of Assessment of Dual Antiplatelet Therapy Versus Rivaroxaban…
Dual Anti-thrombotic Therapy Safe For Patients with Atrial Fibrillation and Recent PCI:ENTRUST-AF PCI
Results from a phase-IIIb, open-label, multi-center, randomized clinical trial comparing the safety…
Population Based Cohort Study: With or Without AFib, CHA₂DS₂-VASc Score is a Sensitive Predictor and Stratifies the Risk of MACCE
Giulia Renda et al. recently published in the European Journal of Preventive…
ORBIT-AF Registry: INR Metrics Associated with Bleeding but Not Ischemia
Among patients with atrial fibrillation (AF) treated with warfarin, clinical risk scores…
New Study Demonstrates Significant Burden of New Onset Atrial Fibrillation in Patients Undergoing Aortic Valve Replacement
A study led by Dr. Rajat Kalra published in JAMA Internal Medicine…
AUGUSTUS: Less Bleeding and Fewer Hospitalizations Without Significant Differences in Ischemic Events With Apixaban and No Aspirin in Patients With AFib and ACS
ACC 2019: In patients with atrial fibrillation and a recent acute coronary…
HEARTLINE: A 180,000 Patient-Strong, Pragmatic, Real World Randomized Trial Assesses the Prowess of Apple Technology in Afib Diagnosis and Improvement of Hard Outcomes
The design of the HEARTLINE randomized trial of up to 180,000 pts…
Nationwide Comparison of Oral Anticoagulants in Nonvalvular Atrial Fibrillation Patients of Low Body Weight
The first nationwide comparison of the effectiveness and safety of warfarin and…
Major Bleeding Rates With Antithrombotic Therapy in Atrial Fibrillation
The results of a study conducted by Rein et al. have shown…
Does Race/Ethnicity Affect Oral Anticoagulant Use in Patients With Atrial Fibrillation?
A study by Essien and his colleagues published in JAMA aimed to…